Clinical trials for psychotropic medication typically involve an elaborate screening process, where patients are required to meet complex inclusion and…
Ana Todorovic, Sophie Gibbons, Philip Craig, Benjamin Fell IntroductionPsychotropic drug trials often involve a substantial period of patient recruitment. Psychiatrists…
Names: Panagiota Kontari, Sophie Gibbons, Simon Pilinger, Elizabeth Ford, Benjamin Fell Background Using electronic health records (EHRs) as a source…
Background: Oxford Mental Illness and Suicide tool (OxMIS) is a brief, scalable, freely available, structured risk assessment tool to assess suicide risk in…
Is Regulation A Barrier to Innovation? Yes. Undeniably, unequivocally, yes. That is not a particularly satisfying answer, is it? The…
Findings from the Angela Project Neuropsychiatry and behavioural neurology/assessment/measurement of neuropsychiatric/behavioural and psychological symptoms Background The presentation of dementia in…
Our approach to accelerating research is grounded in the principle of data protection by design and default. The technologies and…
As we know, medical records can cover a long history of diseases (as Akrivia Health has found up to ninety…
Natural Language Processing (NLP) is a form of Artificial Intelligence which processes language. Natural Language Processing (NLP) has existed for…
It is difficult to imagine the world of science without its laws dictating the need for clinical trials. Most probably…
It is probably true to say one of the most terrifying aspects of Alzheimer’s Disease (AD) is in its very…
Background: Major depressive disorder (MDD) is common and often has sub-optimal response to treatment. Difficult-to-treat depression (DTD) is a new…
Introduction Akrivia Health works with a network of 16 mental healthcare organisations (the Akrivia Network) providing them with a service.…
MHRA Consultation on Proposals for Legislative Changes to Clinical Trials Introduction Akrivia Health works with a network of 16 mental…
Abstract Background Donepezil, galantamine, rivastigmine and memantine are potentially effective interventions for cognitive impairment in dementia, but the use of…
BACKGROUND Antipsychotic medications such as risperidone, olanzapine and aripiprazole are used to treat psychological and behavioural symptoms among dementia…
